Cyclodextrins in Antiviral Therapeutics and Vaccines

被引:33
|
作者
Braga, Susana Santos [1 ]
Barbosa, Jessica S. [1 ,2 ]
Santos, Nadia E. [1 ]
El-Saleh, Firas [3 ]
Paz, Filipe A. Almeida [2 ]
机构
[1] Univ Aveiro, Dept Chem, LAQV REQUIMTE, P-3810193 Aveiro, Portugal
[2] Univ Aveiro, CICECO Aveiro Inst Mat, Dept Chem, P-3810193 Aveiro, Portugal
[3] Ashland Specialty Ingredients, Paul Thomas Str 56, D-40599 Dusseldorf, Germany
关键词
antiviral drugs; inclusion complexes; cyclodextrins; vaccines; HYDROXYPROPYL-BETA-CYCLODEXTRIN; SIMIAN IMMUNODEFICIENCY VIRUS; INFLUENZA-A VIRUS; SQUALANE-IN-WATER; SULFOLIPO-CYCLODEXTRIN; CHOLESTEROL DEPLETION; ORAL BIOAVAILABILITY; VAGINAL TRANSMISSION; SAQUINAVIR MESYLATE; INCLUSION COMPLEX;
D O I
10.3390/pharmaceutics13030409
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present review describes the various roles of cyclodextrins (CDs) in vaccines against viruses and in antiviral therapeutics. The first section describes the most commonly studied application of cyclodextrins-solubilisation and stabilisation of antiviral drugs; some examples also refer to their beneficial taste-masking activity. The second part of the review describes the role of cyclodextrins in antiviral vaccine development and stabilisation, where they are employed as adjuvants and cryopreserving agents. In addition, cyclodextrin-based polymers as delivery systems for mRNA are currently under development. Lastly, the use of cyclodextrins as pharmaceutical active ingredients for the treatment of viral infections is explored. This new field of application is still taking its first steps. Nevertheless, promising results from the use of cyclodextrins as agents to treat other pathologies are encouraging. We present potential applications of the results reported in the literature and highlight the products that are already available on the market.
引用
收藏
页数:24
相关论文
共 50 条
  • [31] RECENT EXPERIENCE WITH ANTIVIRAL VACCINES
    ZHDANOV, VM
    ANNUAL REVIEW OF MICROBIOLOGY, 1961, 15 : 297 - +
  • [32] FUTURE - ANTIVIRAL DRUGS OR VACCINES
    HAFF, RF
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1970, 173 (01) : 210 - &
  • [33] RECENT PROGRESS IN ANTIVIRAL VACCINES
    BROWN, F
    BRITISH MEDICAL BULLETIN, 1985, 41 (01) : 56 - 58
  • [34] APPROACHES TO THE CONSTRUCTION OF ANTIVIRAL VACCINES
    DZAGUROV, SG
    GNUNI, GN
    KHVOLES, AG
    VOPROSY VIRUSOLOGII, 1984, (02) : 137 - 140
  • [35] Antiviral Vaccines: Successes and Prospects
    Hurwitz, Julia L.
    VIRAL IMMUNOLOGY, 2018, 31 (02) : 79 - 79
  • [36] TOWARDS ANTIVIRAL OLIGOPEPTIDE VACCINES
    NIESTERS, HGM
    VANDERZEIJST, BAM
    MICROBIOLOGICAL SCIENCES, 1984, 1 (03): : 55 - 58
  • [37] Editorial: Plant products for antiviral therapeutics
    Mandal, Anirban
    Hazra, Banasri
    Prajapati, Vijay Kumar
    Moundipa, Paul F. F.
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [38] Nanotechnology-based antiviral therapeutics
    Chakravarty, Malobika
    Vora, Amisha
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2021, 11 (03) : 748 - 787
  • [39] Broad-Spectrum Antiviral Therapeutics
    Rider, Todd H.
    Zook, Christina E.
    Boettcher, Tara L.
    Wick, Scott T.
    Pancoast, Jennifer S.
    Zusman, Benjamin D.
    PLOS ONE, 2011, 6 (07):
  • [40] Nanotechnology-based antiviral therapeutics
    Malobika Chakravarty
    Amisha Vora
    Drug Delivery and Translational Research, 2021, 11 : 748 - 787